The use of GLP-1 analogues was associated with an increased risk of bile duct and gallbladder disease. Physicians should be aware of this potential adverse event when prescribing these drugs.
No takes yet. Share an insight, caveat, or question.
Faillie et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: